Endovascular Laser Treatment of Varicose Veins

Information

  • Research Project
  • 6790306
  • ApplicationId
    6790306
  • Core Project Number
    R43HL076931
  • Full Project Number
    1R43HL076931-01
  • Serial Number
    76931
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/1/2004 - 20 years ago
  • Project End Date
    9/30/2005 - 19 years ago
  • Program Officer Name
    ERSHOW, ABBY
  • Budget Start Date
    4/1/2004 - 20 years ago
  • Budget End Date
    9/30/2005 - 19 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    3/18/2004 - 20 years ago
Organizations

Endovascular Laser Treatment of Varicose Veins

DESCRIPTION (provided by applicant): The objective of the proposed study is to develop a endovascular diode-laser based technique at a new wavelength for photothermal coagulation and destruction of the greater saphenous vein (GSV) for treatment of varicose veins. Varicose veins are a significant medical and cosmetic problem with high incidence, especially among women. The cause of varicose veins is reflux and pooling of blood due to incompetent venous valves. Traditional surgical methods have several limitations and endovascular RF and laser treatments are being increasingly used. The current endovascular treatments are highly effective but have certain limitations such as ease of use and unintended side effects of bruising and tenderness. The proposed treatment method with the new wavelength laser is expected to overcome these limitations. Specific aims of the study include: 1. Building a CW fiber coupled laser system, 2. Building a fiber delivery system with an automated constant speed pullback, 3. Demonstrating full thickness vein wall damage in an ex vivo porcine vein model, and 4. Optimizing the treatment parameters for maximal efficacy and minimal side effects. Successful completion of Phase I research will lead to an SBIR phase II proposal emphasizing the development of a commercially oriented laser system for treatment of varicose veins.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    79234
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:79234\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CANDELA CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    WAYLAND
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01778
  • Organization District
    UNITED STATES